Mylan Names Specialty President

Roger Graham has been appointed president of Mylan Specialty and will report to Tony Mauro, president of Mylan North America.

Mr. Graham joins the company from Advandx, a private developer of in-vitro diagnostic tests in the infectious disease space, where he served as chief commercial officer and developed its growth strategy for the U.S. and European markets. Prior to that, he spent nearly a decade in executive-level marketing and sales positions at three brand pharmaceutical firms, Auxilium Pharmaceuticals, Adolor Corp. and Yamanouchi Pharma America. Earlier, Mr. Graham worked at Ortho McNeil, a division of Johnson & Johnson, where he was vice president of the company’s $2 billion anti-infective, analgesia and urology franchise, and its 2,300 primary care and hospital sales and marketing associates.

Mylan chief executive officer Heather Bresch said, “Roger’s deep brand pharmaceutical industry experience, entrepreneurial mind-set and goal-oriented leadership make him the ideal candidate to lead Mylan Specialty as we continue to expand this important business. We remain very excited about the growth prospects of the Specialty business and are confident that Roger will bring immediate value to our entire North American organization and help accelerate achievement of our ambitions for Mylan Specialty.”